Nomi ®

Zolmitriptan
Anti-migraine (CNS Preparations)

Indication:

Nomi^® Tablet: Acute treatment of migraine in adults.
Nomi^® Nasal Spray: Acute treatment of migraine in adults and pediatric patients (12-17 years age).

Dosage & Administration:

The initial recommended dose is 2.5 mg. If symptoms persist or return within 24 hours, a second dose has been shown to be effective but should not be taken within 2 hours of the initial dose.

Preparation:

Nomi^® Tablet: Box containing 12 tablets in blister pack.
Nomi^® Nasal Spray: Each bottle contains solution adequate for 14 metered doses.